title: The effect of lead on iron uptake from transferrin in human erythroleukemia (K562) cells.
abstract: The effect of lead on cellular iron metabolism has been investigated using human erythroleukemia (K562) cells. When the cells were cultured with 100 microM Pb2+ for 48 h, the rate of cellular iron uptake from transferrin decreased to 46% of that in untreated cells. Scatchard analysis of the binding data revealed that this reduction was the result of a decrease in the number of transferrin receptors rather than an alteration in ligand-receptor affinity. The results of immunoprecipitation of transferrin receptors on the cell surface also confirmed the decreased expression of transferrin receptors by lead-treated cells. The down-regulation of transferrin receptors by treatment with lead did not result from a decrease in the total amount of the receptor, as determined by immunoblotting. Moreover, the biosynthesis of the receptor was unaffected by lead treatment. Thus, the down-regulation of surface transferrin receptors in lead-treated cells might be due to a redistribution of receptors rather than an actual loss of receptors from the cell. Using kinetic analysis, it was shown that redistribution of the receptor did not result from the alteration in the rates of transferrin receptor recycling. A comparison of the amounts of transferrin receptor on the cell surface and in the cycling pool revealed that the sequestration of the receptor from normal flow through the cycle might cause down-regulation of the surface receptor.
authors.affiliation: Department of Hygiene, Kansai Medical University, Osaka, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Kohno
authors.forename: S
authors.initials: S
authors.lastname: Taketani
authors.forename: R
authors.initials: R
authors.lastname: Tokunaga
mesh_terms: D001692:Biological Transport; D002462:Cell Membrane / Q000378:metabolism; D004705:Endocytosis / Q000187:drug effects; D006801:Humans; D007501:Iron / Q000378:metabolism*; D007700:Kinetics; D007854:Lead / Q000494:pharmacology*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive; D011990:Receptors, Transferrin / Q000187:drug effects / Q000302:isolation & purification / Q000378:metabolism; D014168:Transferrin / Q000378:metabolism*; D014407:Tumor Cells, Cultured
chemical_list: D011990:Receptors, Transferrin; D014168:Transferrin; D007854:Lead; D007501:Iron